Tough-to-Treat UTIs More Likely to Recur
MONDAY, Nov. 12, 2018 -- If your urinary tract infection isn't responding to antibiotics, you could be headed for a fast relapse, researchers say.
In a new study of 151 adults with antibiotic-resistant UTIs, investigators found that these patients were more likely to have a relapse within a week and were more likely to be prescribed an incorrect antibiotic than a comparison group of patients with non-resistant UTIs.
"This study adds to the evidence that drug-resistant bacteria are an increasing issue, even in the community and even in patients who have something seemingly uncomplicated, like a urinary tract infection," said study lead author Dr. Judith Anesi. She's a clinical epidemiologist and infectious disease fellow at Penn Medicine in Philadelphia.
The study was published recently in the journal Infection Control & Hospital Epidemiology.
"These drug-resistant infections are difficult to treat, and our study shows that relapses are common. This is an alarming finding, and interventions to curb antibiotic resistance are urgently needed," Anesi said in a journal news release.
If patients have antibiotic-resistant UTIs, they should be followed closely for a longer time, and patients at risk for resistant bacteria should have their urine collected and tested, the study authors suggested.
© 2020 HealthDay. All rights reserved.
Posted: November 2018
Read this next
MONDAY, July 20, 2020 -- Hormone replacement therapy (HRT) might be able to break the cycle of recurring urinary tract infections in some women, a new study reports. Women taking...
MONDAY, May 11, 2020 -- Many COVID-19 patients are at risk for acute kidney failure, according to a new study. Acute kidney failure -- also called acute kidney injury (AKI) -- is...
THURSDAY, Jan. 30, 2020 -- Urinary tract infections plague millions of Americans. Now new research suggests that what they eat might have a role to play. The Taiwanese study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.